Table 1 Results of the primary survey

Etiology of CS treated at RC^a

Benign adrenal CS

39 (93%)

Malignant adrenal CS

31 (74%)

Cushing’s disease

40 (95%)

Ectopic CS

33 (79%)

Whole spectrum of CS (i.e. benign adrenal CS, malignant adrenal CS, CD and ectopic CS) treated at RC

27 (64%)

Treatment modalities for CS available at RC

Surgery + medical treatment

3 (7%)

Surgery + medical treatment + combination therapy^b

2 (5%)

Surgery + medical treatment + combination therapy^b + radiotherapy

36 (86%)

Combination therapy^b

1 (2%)

Preoperative medical treatment routinely provided at RC, yes (%)

16 (38%)

Thromboprophylaxis routinely provided at RC, yes (%)

31 (74%)

If yes, setting^a

In the inpatient setting

25/31 (81%)

In the ambulatory setting

6/31 (19%)

Presence of a thromboprophylaxis protocol for patients with CS, yes (%)

11 (26%)

Registration of bleeding complication, yes (%)

18 (43%)

Documentation of severity and outcome of bleeding, yes (%)

22 (52%)

Registration of TE events, yes (%)

24 (57%)

If yes, specific registration of

PE + DVT

7/24 (29%)

PE + DVT + AT

17/24 (71%)